您的位置: 首页 > 农业专利 > 详情页

PHARMACEUTICAL COMPOSITION FOR TREATING A METABOLIC SYNDROME
专利权人:
SANOFI
发明人:
SOMMERFELD, MARK,SCHAEFER, HANS-LUDWIG,BOSCHEINEN, OLIVER,HABERMANN, PAUL,RAO, ERCOLE,DREYER, MATTHIAS
申请号:
SG2012054045
公开号:
SG182652A1
申请日:
2011.01.21
申请国别(地区):
SG
年份:
2012
代理人:
摘要:
The invention is directed to a pharmaceutical composition containing at least one FGF-21 (fibroblast growth factor 21) compound, at least one GLP-1R (glucagon-like peptide-1 receptor) agonist and optionally at least one anti-diabetic drug and/or at least one DPP-4 (dipeptidyl peptidase-4) inhibitor for the treatment of at least one metabolic syndrome and/or atherosclerosis, in particular diabetes, dyslipidemia, obesity and/or adipositas.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充